Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03178396 · ClinicalTrials.gov registry record · NA
Effects and Mechanisms of Melatonin on Blood Pressure, Insulin Resistance, and Platelets
A NA study, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT03178396 is a NA study that has completed, run by Thomas Jefferson University. The registered enrollment target is 31 participants.
The verdict
NCT03178396, a NA study, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The investigators will be studying the effect of melatonin on blood pressure, insulin resistance, and platelets, along with possible reasons for how melatonin cases these effects.
Interventions
- DIETARY_SUPPLEMENT melatonin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2015-12-07 |
| Est. Completion | 2016-08-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03178396
The ClinicalTrials.gov registry entry for NCT03178396 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which melatonin is the first listed.
NCT03178396 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03178396 about?
NCT03178396 is a clinical study titled "Effects and Mechanisms of Melatonin on Blood Pressure, Insulin Resistance, and Platelets". The investigators will be studying the effect of melatonin on blood pressure, insulin resistance, and platelets, along with possible reasons for how melatonin cases these effects.
What is the current status of trial NCT03178396?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2015-12-07. Estimated completion is 2016-08-09.
What interventions are being tested in trial NCT03178396?
The interventions under investigation include: melatonin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03178396?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.